Journal Article
. 2009 Apr;1(4).
doi: 10.1016/j.molonc.2007.12.001.

Prognostic factors versus predictive factors: Examples from a clinical trial of erlotinib

Gary M Clark 1 
Affiliations
  • PMID: 19383314
  •     13 References
  •     45 citations

Abstract

It would be helpful to have factors that could identify patients who will, or will not, benefit from treatment with specific therapies. Ideally, these should be molecular-based factors. When results with molecular-based factors are disappointing, physicians often use clinical characteristics to make treatment decisions. Several characteristics have been suggested to predict sensitivity to epidermal growth factor receptor inhibitors in patients with non-small lung cancer, including gender, histology, smoking history. This report demonstrates that gender and histology are actually prognostic, rather than predictive factors. Before biomarkers or clinical characteristics are included in guidelines for selecting patients for specific treatments, it is imperative that the prognostic effects of these factors are distinguished from their ability to predict a differential clinical benefit from the specific treatment.

Erlotinib in previously treated non-small-cell lung cancer.
Frances A Shepherd, José Rodrigues Pereira, +17 authors, National Cancer Institute of Canada Clinical Trials Group.
N Engl J Med, 2005 Jul 15; 353(2). PMID: 16014882
Highly Cited.
Risk factors differ for non-small-cell lung cancers with and without EGFR mutation: assessment of smoking and sex by a case-control study in Japanese.
Keitaro Matsuo, Hidemi Ito, +7 authors, Tetsuya Mitsudomi.
Cancer Sci, 2006 Oct 24; 98(1). PMID: 17054433
Smoking history and epidermal growth factor receptor expression as predictors of survival benefit from erlotinib for patients with non-small-cell lung cancer in the National Cancer Institute of Canada Clinical Trials Group study BR.21.
Gary M Clark, Denni M Zborowski, +5 authors, National Cancer Institute of Canada Clinical Trials Group.
Clin Lung Cancer, 2006 Jun 28; 7(6). PMID: 16800964
Erlotinib: optimizing therapy with predictors of response?
Susan Goodin.
Clin Cancer Res, 2006 May 19; 12(10). PMID: 16707589
Prognostic factors versus predictive factors: Examples from a clinical trial of erlotinib.
Gary M Clark.
Mol Oncol, 2009 Apr 23; 1(4). PMID: 19383314    Free PMC article.
Female sex and bronchioloalveolar pathologic subtype predict EGFR mutations in non-small cell lung cancer.
Ruey-Kuen Hsieh, Ken-Hong Lim, +2 authors, Ming-Jer Huang.
Chest, 2005 Jul 09; 128(1). PMID: 16002952
The validation of surrogate endpoints in meta-analyses of randomized experiments.
M Buyse, G Molenberghs, +2 authors, H Geys.
Biostatistics, 2003 Aug 23; 1(1). PMID: 12933525
Highly Cited.
Gefitinib therapy for non-small cell lung cancer.
Ariel Birnbaum, Neal Ready.
Curr Treat Options Oncol, 2004 Dec 22; 6(1). PMID: 15610717
Review.
Clinical utility of epidermal growth factor receptor expression for selecting patients with advanced non-small cell lung cancer for treatment with erlotinib.
Gary M Clark, Denni M Zborowski, +4 authors, Frances A Shepherd.
J Thorac Oncol, 2007 Apr 06; 1(8). PMID: 17409968
Practical management of patients with non-small-cell lung cancer treated with gefitinib.
Neelam T Shah, Mark G Kris, +7 authors, Vincent A Miller.
J Clin Oncol, 2004 Nov 24; 23(1). PMID: 15557594
Gefitinib plus best supportive care in previously treated patients with refractory advanced non-small-cell lung cancer: results from a randomised, placebo-controlled, multicentre study (Iressa Survival Evaluation in Lung Cancer).
Nick Thatcher, Alex Chang, +8 authors, Kevin Carroll.
Lancet, 2005 Nov 01; 366(9496). PMID: 16257339
Highly Cited.
Objective response rate as a surrogate end point: a commentary.
Thomas R Fleming.
J Clin Oncol, 2005 Jun 16; 23(22). PMID: 15955898
Clinicopathologic characteristics of the EGFR gene mutation in non-small cell lung cancer.
Anne S Tsao, Xi Ming Tang, +7 authors, Ignacio Wistuba.
J Thorac Oncol, 2007 Apr 06; 1(3). PMID: 17409862
Overcoming CYP1A1/1A2 mediated induction of metabolism by escalating erlotinib dose in current smokers.
Andrew N Hughes, Mary E R O'Brien, +8 authors, Allan Price.
J Clin Oncol, 2009 Jan 24; 27(8). PMID: 19164205    Free PMC article.
Bladder cancer-associated protein, a potential prognostic biomarker in human bladder cancer.
José M A Moreira, Gita Ohlsson, +4 authors, Irina Gromova.
Mol Cell Proteomics, 2009 Sep 29; 9(1). PMID: 19783793    Free PMC article.
EGFR inhibitors in non-small cell lung cancer (NSCLC): the emerging role of the dual irreversible EGFR/HER2 inhibitor BIBW 2992.
James F Spicer, Sarah M Rudman.
Target Oncol, 2010 Jun 25; 5(4). PMID: 20574858
Review.
Smoking habits in elderly lung cancer patients: still no changes in epidemiology? A single-center experience.
Regina Gironés Sarrió, María Dolores Torregrosa, +2 authors, Rafael Rosell.
Clin Transl Oncol, 2010 Oct 16; 12(10). PMID: 20947483
Prognostic and predictive value of a malignancy-risk gene signature in early-stage non-small cell lung cancer.
Dung-Tsa Chen, Ying-Lin Hsu, +4 authors, W Douglas Cress.
J Natl Cancer Inst, 2011 Dec 14; 103(24). PMID: 22157961    Free PMC article.
Tissue biomarkers for prostate cancer radiation therapy.
P T Tran, R K Hales, +10 authors, T L DeWeese.
Curr Mol Med, 2012 Feb 02; 12(6). PMID: 22292443    Free PMC article.
Review.
Swedish lung cancer radiation study group: the prognostic value of anaemia, thrombocytosis and leukocytosis at time of diagnosis in patients with non-small cell lung cancer.
Georg Holgersson, Martin Sandelin, +15 authors, Michael Bergqvist.
Med Oncol, 2012 May 09; 29(5). PMID: 22565809
Validation of a radiosensitivity molecular signature in breast cancer.
Steven A Eschrich, William J Fulp, +9 authors, Javier F Torres-Roca.
Clin Cancer Res, 2012 Jul 27; 18(18). PMID: 22832933    Free PMC article.
Personalized medicine in breast cancer: a systematic review.
Sang-Hoon Cho, Jongsu Jeon, Seung Il Kim.
J Breast Cancer, 2012 Oct 24; 15(3). PMID: 23091538    Free PMC article.
A molecular assay of tumor radiosensitivity: a roadmap towards biology-based personalized radiation therapy.
Javier F Torres-Roca.
Per Med, 2012 Oct 30; 9(5). PMID: 23105945    Free PMC article.
Predicting outcomes in radiation oncology--multifactorial decision support systems.
Philippe Lambin, Ruud G P M van Stiphout, +11 authors, Andre Dekker.
Nat Rev Clin Oncol, 2012 Nov 21; 10(1). PMID: 23165123    Free PMC article.
Highly Cited. Review.
Prognosis research strategy (PROGRESS) 4: stratified medicine research.
Aroon D Hingorani, Daniëlle A van der Windt, +8 authors, PROGRESS Group.
BMJ, 2013 Feb 07; 346. PMID: 23386361    Free PMC article.
Highly Cited.
Prognosis Research Strategy (PROGRESS) 2: prognostic factor research.
Richard D Riley, Jill A Hayden, +9 authors, PROGRESS Group.
PLoS Med, 2013 Feb 09; 10(2). PMID: 23393429    Free PMC article.
Highly Cited. Review.
Prospective, longitudinal, multi-modal functional imaging for radical chemo-IMRT treatment of locally advanced head and neck cancer: the INSIGHT study.
Liam Welsh, Rafal Panek, +17 authors, Kate Newbold.
Radiat Oncol, 2015 May 15; 10. PMID: 25971451    Free PMC article.
Biomarkers and targeted systemic therapies in advanced non-small cell lung cancer.
Mukesh Kumar, Vinicius Ernani, Taofeek K Owonikoko.
Mol Aspects Med, 2015 Jul 19; 45. PMID: 26187108    Free PMC article.
Review.
Prognosis Relevance of Serum Cytokines in Pancreatic Cancer.
Carolina Torres, Ana Linares, +10 authors, Sonia Perales.
Biomed Res Int, 2015 Sep 09; 2015. PMID: 26346854    Free PMC article.
Integration of a Radiosensitivity Molecular Signature Into the Assessment of Local Recurrence Risk in Breast Cancer.
Javier F Torres-Roca, William J Fulp, +6 authors, Steven A Eschrich.
Int J Radiat Oncol Biol Phys, 2015 Oct 16; 93(3). PMID: 26461005    Free PMC article.
Strategies for power calculations in predictive biomarker studies in survival data.
Dung-Tsa Chen, Po-Yu Huang, +4 authors, Jhanelle E Gray.
Oncotarget, 2016 Sep 24; 7(49). PMID: 27661007    Free PMC article.
Southwestern Oncology Group pretreatment risk criteria as predictive or prognostic factors in acute myeloid leukemia.
Ana Espirito Santo, Sergio Chacim, +12 authors, Rui Medeiros.
Mol Clin Oncol, 2017 Apr 30; 6(3). PMID: 28451418    Free PMC article.
Beyond Correlations, Sensitivities, and Specificities: A Roadmap for Demonstrating Utility of Advanced Imaging in Oncology Treatment and Clinical Trial Design.
Erich P Huang, Frank I Lin, Lalitha K Shankar.
Acad Radiol, 2017 May 01; 24(8). PMID: 28456570    Free PMC article.
Review.
Accurate and dynamic predictive model for better prediction in medicine and healthcare.
H O Alanazi, A H Abdullah, K N Qureshi, A S Ismail.
Ir J Med Sci, 2017 Aug 02; 187(2). PMID: 28756541
Evaluation of biomarkers for treatment selection using individual participant data from multiple clinical trials.
Chaeryon Kang, Holly Janes, +7 authors, Maureen Franssen.
Stat Med, 2018 Feb 15; 37(9). PMID: 29444553    Free PMC article.
Treatment-Related Predictive and Prognostic Factors in Trimodality Approach in Stage IIIA/N2 Non-Small Cell Lung Cancer.
Branislav Jeremić, Francesc Casas, +4 authors, Ivan Igrutinovic.
Front Oncol, 2018 Mar 13; 8. PMID: 29527511    Free PMC article.
Review.
Distinguishing prognostic and predictive biomarkers: an information theoretic approach.
Konstantinos Sechidis, Konstantinos Papangelou, +3 authors, Gavin Brown.
Bioinformatics, 2018 May 05; 34(19). PMID: 29726967    Free PMC article.
Pre-treatment hemoglobin levels are an independent prognostic factor in patients with non-small cell lung cancer.
Yue-Hua Zhang, Yuquan Lu, +5 authors, Xiao-Yan Zhao.
Mol Clin Oncol, 2018 Jun 14; 9(1). PMID: 29896399    Free PMC article.
Clinical relevance of the 21-gene Recurrence Score® assay in treatment decisions for patients with node-positive breast cancer in the genomic era.
Eleftherios P Mamounas, Christy A Russell, +2 authors, Kathy S Albain.
NPJ Breast Cancer, 2018 Aug 30; 4. PMID: 30155517    Free PMC article.
Review.
Tuberculosis: mother of thoracic surgery then and now, past and prospectives: a review.
Tamas F Molnar.
J Thorac Dis, 2018 Oct 23; 10(Suppl 22). PMID: 30345099    Free PMC article.
Review.
Predicting Outcomes From Radical Radiotherapy for Non-small Cell Lung Cancer: A Systematic Review of the Existing Literature.
Gerard M Walls, Gerard G Hanna, +4 authors, David Landau.
Front Oncol, 2018 Oct 27; 8. PMID: 30364202    Free PMC article.
Multigene expression signatures in early hormone receptor positive HER 2 negative breast cancer.
Tanja Ovcaricek, Iztok Takac, Erika Matos.
Radiol Oncol, 2019 Sep 26; 53(3). PMID: 31553709    Free PMC article.
Review.
Prognostic and predictive value of nuclear imaging in endocrine oncology.
Giorgio Treglia, Bernard Goichot, +6 authors, Alessio Imperiale.
Endocrine, 2019 Nov 18; 67(1). PMID: 31734779    Free PMC article.
Review.
Prognostic factors versus predictive factors: Examples from a clinical trial of erlotinib.
Gary M Clark.
Mol Oncol, 2009 Apr 23; 1(4). PMID: 19383314    Free PMC article.
Redefining the role of biomarkers in heart failure trials: expert consensus document.
Frank Kramer, Hani N Sabbah, +13 authors, Mihai Gheorghiade.
Heart Fail Rev, 2017 Mar 24; 22(3). PMID: 28332132
Review.
Prognostic Factors for Physical Functioning After Multidisciplinary Rehabilitation in Patients With Chronic Musculoskeletal Pain: A Systematic Review and Meta-Analysis.
Elena Tseli, Katja Boersma, +4 authors, Wilhelmus J A Grooten.
Clin J Pain, 2018 Oct 30; 35(2). PMID: 30371517    Free PMC article.
Systematic Review.
An overview of precision oncology basket and umbrella trials for clinicians.
Jay J H Park, Grace Hsu, +2 authors, Edward J Mills.
CA Cancer J Clin, 2020 Feb 08; 70(2). PMID: 32031692    Free PMC article.
Review.
Prognostic Value of Pretreatment Systemic Immune-Inflammation Index in Glioblastoma Multiforme Patients Undergoing Postneurosurgical Radiotherapy Plus Concurrent and Adjuvant Temozolomide.
Erkan Topkan, Ali Ayberk Besen, +4 authors, Ugur Selek.
Mediators Inflamm, 2020 Jun 23; 2020. PMID: 32565725    Free PMC article.
Model-based meta-analysis of individual International Prostate Symptom Score trajectories in patients with benign prostatic hyperplasia with moderate or severe symptoms.
Salvatore D'Agate, Timothy Wilson, +6 authors, Oscar Della Pasqua.
Br J Clin Pharmacol, 2020 Mar 08; 86(8). PMID: 32144791    Free PMC article.
The Use of (Network) Meta-Analysis in Clinical Oncology.
Emil Ter Veer, Martijn G H van Oijen, Hanneke W M van Laarhoven.
Front Oncol, 2019 Sep 12; 9. PMID: 31508373    Free PMC article.
Characterizing Exposure-Response Relationship for Therapeutic Monoclonal Antibodies in Immuno-Oncology and Beyond: Challenges, Perspectives, and Prospects.
Haiqing Isaac Dai, Yulia Vugmeyster, Naveen Mangal.
Clin Pharmacol Ther, 2020 Jun 20; 108(6). PMID: 32557643    Free PMC article.
Review.
Prognostic and predictive significance of nuclear HIF1α expression in locally advanced HNSCC patients treated with chemoradiation with or without nimotuzumab.
Usha Patel, Manish Pandey, +10 authors, Manoj B Mahimkar.
Br J Cancer, 2020 Sep 18; 123(12). PMID: 32939054    Free PMC article.
Clinically relevant prognostic and predictive markers for immune-checkpoint-inhibitor (ICI) therapy in non-small cell lung cancer (NSCLC).
Wolfgang M Brueckl, Joachim H Ficker, Gloria Zeitler.
BMC Cancer, 2020 Dec 05; 20(1). PMID: 33272262    Free PMC article.
Review.
Prognostic Factors in Canine Acute Intervertebral Disc Disease.
Natasha J Olby, Ronaldo C da Costa, +2 authors, Canine Spinal Cord Injury Consortium (CANSORT SCI).
Front Vet Sci, 2020 Dec 17; 7. PMID: 33324703    Free PMC article.
Review.
Prognostic Factors Determining Survival of Patients Operated for Non-Small Cell Lung Cancer with Consideration Given to Morphological Parameters of Blood.
Mariusz Łochowski, Barbara Łochowska, +3 authors, Józef Kozak.
Cancer Manag Res, 2021 Jan 28; 13. PMID: 33500661    Free PMC article.
Risk stratification tools in prostate cancer, where do we stand?
Andries Clinckaert, Gaëtan Devos, Eduard Roussel, Steven Joniau.
Transl Androl Urol, 2021 Feb 04; 10(1). PMID: 33532290    Free PMC article.
A Phenomic Perspective on Factors Influencing Breast Cancer Treatment: Integrating Aging and Lifestyle in Blood and Tissue Biomarker Profiling.
Ainhoa Arana Echarri, Mark Beresford, +6 authors, James E Turner.
Front Immunol, 2021 Feb 19; 11. PMID: 33597950    Free PMC article.
Review.
Implementing Precision Psychiatry: A Systematic Review of Individualized Prediction Models for Clinical Practice.
Gonzalo Salazar de Pablo, Erich Studerus, +9 authors, Paolo Fusar-Poli.
Schizophr Bull, 2020 Sep 12; 47(2). PMID: 32914178    Free PMC article.